Related Experiment Video
Updated: Jul 1, 2026

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
Pathological autoantibodies in cardiomyopathy.
Roland Jahns1, Valérie Boivin, Valentin Schwarzbach
1Department of Internal Medicine, Medizinische Klinik und Poliklinik I, Cardiology, University of Würzburg, Würzburg, Germany.
Autoimmune reactions targeting heart muscle antigens may cause dilated cardiomyopathy (DCM). Certain autoantibodies, when transferred, can induce cardiac dysfunction, suggesting a pathogenic role in heart failure.
Area of Science:
- Cardiology
- Immunology
- Pathophysiology
Background:
- Idiopathic dilated cardiomyopathy (iDCM) is characterized by heart muscle enlargement and dysfunction without significant coronary artery disease.
- Potential etiologies for DCM include genetic, toxic, infectious, and immune-mediated causes.
- Emerging evidence suggests autoimmune reactions against myocyte antigens contribute to DCM development and progression.
Purpose of the Study:
- To review evidence implicating specific autoantibodies in the pathogenesis of dilated cardiomyopathy.
- To explore the role of autoimmune mechanisms in heart muscle damage and subsequent heart failure.
Main Methods:
- Review of recent research, including animal transfer experiments (primarily in rodents) and preliminary clinical data.
- Analysis of evidence supporting the pathogenic potential of autoantibodies against cardiac antigens.
Main Results:
- Some autoantibodies directed against specific cardiac antigens have demonstrated pathogenic capabilities.
- These autoantibodies can independently cause cardiac dysfunction and heart failure in experimental models.
- Autoimmune reactions are hypothesized to arise from myocyte damage (viral, ischemic, toxic) releasing self-antigens.
Conclusions:
- Autoimmune responses against cardiac antigens are implicated in the pathogenesis of dilated cardiomyopathy.
- Specific autoantibodies may play a direct role in causing heart failure.
- Further research is warranted to elucidate the precise mechanisms and clinical relevance of these autoimmune findings in DCM.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

